1 / 9

BIOTECHNOLOGY IN ISRAEL – TRENDS

BIOTECHNOLOGY IN ISRAEL – TRENDS. Dr. Haim Aviv. Opportunity. Good science Motivated people International outlook (US oriented Critical mass (160 companies). Profile of Biotechnology Companies 1990-2000*. * From The National Biotechnology Committee’s Report. Challenges.

zion
Download Presentation

BIOTECHNOLOGY IN ISRAEL – TRENDS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BIOTECHNOLOGY IN ISRAEL –TRENDS Dr. Haim Aviv

  2. Opportunity • Good science • Motivated people • International outlook (US oriented • Critical mass (160 companies)

  3. Profile of Biotechnology Companies 1990-2000* * From The National Biotechnology Committee’s Report

  4. Challenges • Managerial skills & experience • Financial resources • Political & geographic conditions

  5. Issues • Probability for billion dollar companies? - Depends on successful development of one/two major products - Stay independent

  6. Pharmos Corporation • Neuroprotective dexanabinol in Phase III trial for traumatic brain injury. Market potential – billion $. • Product for stroke after preclinical testing, beginning tox Studies. • Novel compounds identified for pain, autoimmune and vascular diseases

  7. 2. Production in Israel or license out? - Collaboration/partnerships vs. license - Production in Israel (not critical)

  8. Israel as development center - Political & Geographic constrains - Partnerships/co-development

  9. 4. Mergers & Equisitions - M&A between “Israeli” corporations - M&A with “non Israeli” organizations. Will depend on exciting products and technologies

More Related